Atlassian Announces Date for First Quarter of Fiscal Year 2026 Financial Results

Atlassian Corporation (NASDAQ: TEAM), a leading provider of TEAM collaboration and productivity software, today announced that it will release financial results for its first quarter of fiscal year 2026 ended September 30, 2025 after market close on Thursday, October 30, 2025. Atlassian will host a conference call to discuss the financial results at 2:00 P.M. Pacific Time. In conjunction with its earnings press release, Atlassian will post a shareholder letter to the Investor Relations section of its website at https://investors.atlassian.com .

Webcast Details

  • When : Thursday, October 30, 2025 at 2:00 P.M. Pacific Time (5:00 P.M. Eastern Time).
  • Webcast : A live webcast of the call can be accessed from the Investor Relations section of Atlassian's website at https://investors.atlassian.com . Following the call, a replay will be available on the same website.

Atlassian has used, and intends to continue to use, the Investor Relations section of its website ( https://investors.atlassian.com ), as a means of disclosing material non-public information and for complying with its disclosure obligations.

About Atlassian

Atlassian unleashes the potential of every team. A recognized leader in software development, work management, and enterprise service management software, Atlassian enables enterprises to connect their business and technology teams with an AI-powered system of work that unlocks productivity at scale. Atlassian's collaboration software powers over 80% of the Fortune 500 and 300,000+ customers worldwide - including NASA, Rivian, Deutsche Bank, United Airlines, and Bosch - who rely on our solutions to drive work forward.

Investor Relations Contact
Martin Lam
IR@atlassian.com

Media Contact
Marie-Claire Maple
press@atlassian.com

News Provided by Business Wire via QuoteMedia

TEAM
The Conversation (0)
Revolve Renewable Power Corp. (TSXV:REVV)

Revolve Expands Mexico Distributed Generation Business with New Partnership

Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy projects, is pleased to announce it has signed a partnership agreement dated October 8, 2025 with an experienced Engineer, Procure and Construct... Keep Reading...
Gold Mining Stocks Poised for Windfall as Prices Top $4,000 Per Ounce

Gold Mining Stocks Poised for Windfall as Prices Top $4,000 Per Ounce

USA News Group News Commentary Issued on behalf of GoldHaven Resources Corp. USA News Group News Commentary Gold smashed through $4,000 per ounce for the first time in history this week, surging over 50% year-to-date as the US government shutdown, ongoing Fed rate cuts, and global economic... Keep Reading...
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. Neil Klompas, CPA, CA to its Board of... Keep Reading...
CHARBONE Hydrogen Successfully Completes the Dismantling of Hydrogen Equipment in Quebec and Announces the Arrival of the Main Components in Sorel-Tracy

CHARBONE Hydrogen Successfully Completes the Dismantling of Hydrogen Equipment in Quebec and Announces the Arrival of the Main Components in Sorel-Tracy

(TheNewswire) Brossard, Quebec, October 9, 2025 TheNewswire - Charbone Hydrogen Corporation (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (" CHARBONE " or the " Company "), a company dedicated to building a North America's first clean Ultra High Purity (" UHP ") hydrogen production and... Keep Reading...
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...

Latest Press Releases

Related News